The Institute of Science and Technology of the University of Navarra and Cepa Schwartz Pharma, a subsidiary of the German company of the same name, have signed in Spain an agreement for the manufacture of drugs to treat memory loss.
The research will be carried out in the Department of Pharmacology of the University of Navarra and will have a budget of 32,5 million pesetas.